Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 15.39%3.91B | 9.41%2.57B | 11.87%1.23B | 17.11%4.7B | 2.18%3.39B | 24.60%2.35B | 14.95%1.1B | 20.01%4.01B | 48.22%3.31B | 30.82%1.88B |
| Refunds of taxes and levies | -92.07%4.84K | -95.66%4.71K | -92.21%4.71K | -7.41%49.67K | 212.35%61.04K | 102.19%108.47K | --60.42K | -99.22%53.65K | -99.71%19.54K | -99.21%53.65K |
| Net deposit increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in borrowings from central bank | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in repurchase business capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Premiums received from original insurance contracts | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net cash received from reinsurance business | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in deposits from policyholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in funds disbursed | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net cash received from trading securities | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | -69.04%34.59M | -73.62%28.39M | -78.89%17.6M | 208.83%176.03M | -87.14%111.71M | 231.38%107.61M | 516.56%83.39M | 39.88%57M | 2,624.65%868.62M | 28.14%32.47M |
| Cash inflows from operating activities | 12.69%3.94B | 5.76%2.6B | 5.44%1.24B | 19.80%4.88B | -16.37%3.5B | 28.11%2.46B | 21.98%1.18B | 20.00%4.07B | 83.88%4.18B | 30.17%1.92B |
| Goods services cash paid | 7.40%2.38B | 1.82%1.48B | -19.72%567.42M | 3.21%3.08B | -9.81%2.22B | 19.10%1.45B | 41.65%706.82M | 21.76%2.99B | 63.34%2.46B | 19.94%1.22B |
| Staff behalf paid | 15.71%554.4M | 15.08%365.37M | 19.61%182.55M | 21.86%658.71M | 22.50%479.14M | 22.93%317.48M | 15.21%152.63M | 28.73%540.54M | 30.70%391.14M | 28.50%258.25M |
| All taxes paid | 6.79%161.96M | 3.18%103.9M | 1.54%41.24M | 12.69%210.23M | 1.00%151.65M | -9.51%100.69M | -35.68%40.62M | 17.99%186.55M | 24.45%150.16M | 30.38%111.27M |
| Net loan and advance increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net deposit in central bank and institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net lend capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid for fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Policy dividend cash paid | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -0.72%256.43M | -36.44%119.78M | -26.85%89.15M | 56.72%352.75M | -70.59%258.28M | 54.11%188.45M | 81.56%121.88M | 20.35%225.08M | 442.42%878.11M | 49.71%122.28M |
| Cash outflows from operating activities | 7.98%3.35B | 0.43%2.07B | -13.85%880.37M | 9.27%4.3B | -19.90%3.1B | 20.32%2.06B | 34.16%1.02B | 22.41%3.94B | 85.83%3.88B | 23.58%1.71B |
| Net cash flows from operating activities | 49.80%589.98M | 33.27%531.67M | 130.62%363.32M | 335.22%571.76M | 28.18%393.84M | 92.23%398.93M | -23.24%157.54M | -24.43%131.37M | 62.34%307.26M | 132.12%207.52M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 108.65%1.51B | 288.03%981.08M | 11.49%380.37M | -40.31%749.24M | -15.93%722.85M | -37.14%252.84M | 59.58%341.16M | 139.76%1.26B | 261.12%859.83M | 110.48%402.2M |
| Cash received from returns on investments | 311.12%4.53M | 205.12%1.38M | 18.95%347.65K | 25.46%1.44M | 4.62%1.1M | -35.16%451.56K | 1,277.16%292.28K | 154.26%1.14M | 172.07%1.05M | 135.78%696.44K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -23.71%372.2K | -31.56%724.11K | 367.29%188.55K | -60.97%2.2M | 14,491.92%487.89K | 26.96%1.06M | --40.35K | 1,025.48%5.65M | -104.81%-3.39K | 1,338.05%833.35K |
| Net cash received from disposal of subsidiaries and other business units | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash received relating to other investing activities | --0 | --0 | --0 | --4M | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash inflows from investing activities | 108.87%1.51B | 286.55%983.18M | 11.54%380.91M | -40.02%756.88M | -15.85%724.44M | -37.00%254.35M | 59.72%341.5M | 140.62%1.26B | 260.87%860.88M | 110.89%403.73M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -26.00%94.5M | -9.47%78.42M | -15.25%42.68M | -25.62%160.89M | -8.27%127.71M | 5.36%86.61M | 10.99%50.37M | 106.46%216.31M | 157.92%139.23M | 193.76%82.21M |
| Cash paid to acquire investments | 82.25%1.58B | 259.07%1.01B | 98.22%667.02M | -43.87%751.08M | -31.61%865.87M | -42.91%281.55M | 47.03%336.51M | 147.66%1.34B | 446.96%1.27B | 154.83%493.13M |
| Net cash paid to acquire subsidiaries and other business units | 125.75%488.95M | 182.38%395.65M | --0 | -35.26%329.33M | 73.60%216.59M | -33.52%140.11M | -14.41%32.71M | 14,459.51%508.68M | 3,470.89%124.76M | 5,932.33%210.76M |
| Impawned loan net increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash paid relating to other investing activities | 6.79%2.53M | 6.79%2.53M | --0 | -46.22%2.53M | -95.96%2.37M | -16.42%2.37M | 46.53%52.75M | -19.94%4.71M | 1,477.40%58.69M | -14.55%2.84M |
| Cash outflows from investing activities | 78.47%2.16B | 191.31%1.49B | 50.25%709.7M | -39.85%1.24B | -23.68%1.21B | -35.27%510.65M | 35.55%472.34M | 215.97%2.07B | 442.85%1.59B | 245.56%788.93M |
| Net cash flows from investing activities | -33.35%-650.89M | -96.79%-504.36M | -151.29%-328.79M | 39.57%-486.95M | 32.95%-488.09M | 33.46%-256.3M | 2.84%-130.84M | -520.08%-805.82M | -1,244.93%-727.94M | -944.95%-385.2M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -97.00%210K | -98.83%72K | --30K | -99.20%7M | -99.23%7M | -99.30%6.15M | --0 | --879.45M | --907.73M | --879.45M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -97.00%210K | --72K | --0 | --7M | --7M | --0 | --0 | ---- | ---- | ---- |
| Cash from borrowing | 7.32%514.24M | 38.03%422.38M | 65.67%148.92M | -42.47%509.49M | 54.07%479.16M | 72.62%306.01M | 165.21%89.89M | 159.01%885.56M | 169.96%311M | 73.40%177.27M |
| Cash received relating to other financing activities | --0 | --0 | --130M | --190.02M | --190.02M | --0 | --0 | ---- | --0 | ---- |
| Cash inflows from financing activities | -23.92%514.45M | 35.33%422.45M | 210.33%278.95M | -59.97%706.51M | -44.52%676.18M | -70.46%312.16M | -90.45%89.89M | 416.23%1.77B | 957.91%1.22B | 933.65%1.06B |
| Borrowing repayment | -45.79%261.44M | -48.85%245.89M | 205.64%246.35M | 46.96%576.76M | 160.43%482.25M | 216.71%480.7M | -31.39%80.6M | 196.35%392.46M | 65.63%185.18M | 106.79%151.78M |
| Dividend interest payment | 50.89%73.92M | 8.38%51.81M | 73.12%5.23M | 281.13%55.98M | 684.46%48.99M | 1,158.98%47.8M | -24.14%3.02M | 255.58%14.69M | 100.71%6.24M | 56.59%3.8M |
| -Including:Cash payments for dividends or profit to minority shareholders | --24.19M | --4.4M | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash payments relating to other financing activities | -29.28%233.35M | 17.63%156.57M | 19.36%64.68M | 93.84%429.54M | 102.84%329.96M | 31.33%133.1M | 13.47%54.19M | 27.95%221.59M | 22.36%162.67M | 18.97%101.34M |
| Cash outflows from financing activities | -33.96%568.71M | -31.34%454.27M | 129.49%316.26M | 68.95%1.06B | 143.22%861.2M | 157.51%661.6M | -18.56%137.81M | 102.98%628.74M | 42.86%354.09M | 59.57%256.92M |
| Net cash flows from financing activities | 70.67%-54.26M | 90.89%-31.82M | 22.15%-37.31M | -131.31%-355.77M | -121.40%-185.03M | -143.69%-349.44M | -106.20%-47.92M | 3,433.77%1.14B | 751.82%864.64M | 1,460.71%799.8M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 1.78%-58.25K | -171.32%-25.59K | -683.67%-7.53K | 19.35%114.62K | -147.58%-59.3K | --35.88K | --1.29K | --96.04K | --124.64K | ---- |
| Net increase in cash and cash equivalents | 58.75%-115.24M | 97.81%-4.54M | 86.87%-2.79M | -158.63%-270.84M | -162.90%-279.35M | -133.24%-206.78M | -102.52%-21.23M | 507.50%461.92M | 17,738.22%444.08M | 10,075.84%622.12M |
| Add:Begin period cash and cash equivalents | -45.62%322.88M | -45.62%322.88M | -45.62%322.88M | 350.45%593.72M | 299.69%593.72M | 350.45%593.72M | 350.45%593.72M | 136.34%131.81M | 166.35%148.54M | 136.34%131.81M |
| End period cash equivalent | -33.95%207.64M | -17.73%318.34M | -44.09%320.09M | -45.62%322.88M | -46.95%314.38M | -48.68%386.95M | -41.27%572.5M | 350.45%593.72M | 917.21%592.62M | 1,422.04%753.92M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.